Join Science 37 at CNS Summit 2022 in Boca Raton, FL, November 17-20, which will bring together a group of top decision-makers from pharma, biotech, CROs, investigator sites, patient advocacy groups, investors and other stakeholders.
A team from Science 37 will be on-site at the event exhibiting, presenting, and participating in important discussions. Visit booth #59 to learn how our Virtual site can deliver success for your next clinical trial.
Chief Executive Officer for Science 37, David Coman, will participate in a keynote session titled When Will DCT 2.0 Be Here, taking place on November 19, 8:00 - 12:00 PM EST.
Don’t miss the Spotlight Session, DCT Town Hall, on November 19, 12:00 PM - 1:50 PM EST where David Coman, Chief Executive Officer for Science 37, will speak on a panel discussion.
Dr. Christopher Reist, Medical Director for Psychiatry and Behavioral Science will present a poster on "Remote Administration of MADRS is Equal in Quality to In-Person Administration: Evidence from Two Parallel Depression Trials". This presentation will take place on November 19th at 5 pm EST.